×
ADVERTISEMENT
ADVERTISEMENT

Novo Nordisk sees 2% sales growth in Q3 as more diabetics seek treatment

The company hopes to gradually replace its US insulin business with the new GLP-1 diabetes drugs
Last Updated : 30 October 2020, 10:05 IST
ADVERTISEMENT

Follow Us :

Comments
ADVERTISEMENT
Published 30 October 2020, 10:04 IST

Follow us on :

Follow Us